Exosome RNA Exosome RNA Research & Industry News
Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not ...
Read More »First exosome-based liquid biopsy test receives FDA’s breakthrough device designation
